02315 BIOCYTOGEN-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.53X | Oper Margin | 16.8% |
|---|---|---|---|
| LT Debt/Equity | 41.3% | Net Margin | 3.4% |
| Total Debt/Equity | 68.4% | Return on Equity | 4.0% |
| Price/Book | 11.63X | Return on Assets | 1.4% |
| (HKD 25.840) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 35.67 | -422.09 | -674.90 | -667.29 | -257.84 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +108.5 | +37.5 | -1.1 | -158.8 | N/A |
| Earnings Per Share (HKD) | 0.09 | -1.06 | -1.771 | -1.841 | -1.998 |
| Earnings Per Share Growth (%) | +108.5 | +40.2 | +3.8 | +7.8 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 288.39 | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 2.221 | 2.169 | 3.218 | N/A | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 620.963 | 410.499 | +51.3 | 326.836 |
| Operating Result | 70.556 | -37.992 | -285.7 | -184.433 |
| Associates | -11.856 | -9.085 | +30.5 | -4.983 |
| Profit Before Taxation | 59.62 | -47.077 | -226.6 | -189.389 |
| Taxation | 11.621 | 3.596 | +223.2 | 0.42 |
| Profit /( Loss) After Taxation | 47.999 | -50.673 | -194.7 | -189.809 |
| Minority Interests | 0 | 0 | N/A | -0.001 |
| Net Profit | 47.999 | -50.673 | -194.7 | -189.808 |
| Earnings Per Share () | 0.1327 | -0.1367 | -197.1 | -0.5142 |
| Announcement Date | 2025-08-28 | 2024-08-28 | NA | 2023-08-28 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
